Table 3.
Cancer site | Race/ethnicity | AD (rate difference) compared with NHWs in same SES group | RD (hazard ratio) compared with NHWs in same SES group | ||
---|---|---|---|---|---|
Q1 | Q5 | Q1 | Q5 | ||
Lung | NHB | −1.1† | −2.9 | 0.93 (0.90–0.95) | 1.00 (0.93–1.08) |
API | −0.1 | −0.4 | 0.76 (0.71–0.80) | 0.78 (0.75–0.82) | |
HISP | −0.5 | −0.1 | 0.95 (0.92–0.99) | 0.97 (0.91–1.03) | |
Liver | NHB | −2.2 | 8.1 | 1.04 (0.96–1.12) | 1.07 (0.87–1.31) |
API | 3.3 | 12.9† | 0.82 (0.75–0.90) | 0.82 (0.75–0.90) | |
HISP | 2.9 | 4.9 | 0.91 (0.85–0.98) | 0.89 (0.78–1.00) | |
Kidney | NHB | 3.1† | 0.4 | 0.98 (0.88–1.09) | 1.20 (0.96–1.51) |
API | −2.6 | −1.3 | 0.98 (0.77–1.25) | 0.96 (0.82–1.21) | |
HISP | 2.4 | 1.5 | 0.95 (0.86–1.05) | 1.03 (0.87–1.23) | |
CRC | NHB | −5.0† | −4.5† | 1.08 (1.03–1.13) | 1.19 (1.07–1.31) |
API | −0.5 | 5.8† | 0.93 (0.85–1.02) | 0.88 (0.82–0.94) | |
HISP | 1.4 | −1.7 | 0.93 (0.88–0.98) | 1.00 (0.92–1.10) | |
Breast | NHB | −7.1† | −6.8† | 1.31 (1.23–1.39) | 1.64 (1.42–1.88) |
API | 2.9† | 1.5† | 0.74 (0.63–0.87) | 0.96 (0.86–1.08) | |
HISP | 1.9† | −2.1† | 1.00 (0.92–1.08) | 1.21 (1.08–1.36) | |
Prostate | NHB | −0.7 | −0.5 | 1.08 (0.99–1.17) | 1.28 (1.07–1.53) |
API | 0.5 | 0.2 | 0.69 (0.55–0.86) | 0.84 (0.71–0.99) | |
HISP | 0.5 | −0.9 | 0.87 (0.79–0.96) | 1.20 (1.01–1.42) |
* Stratified by stage and age at diagnosis with adjustment for sex, cancer-directed surgery, and radiation therapy and interaction between race/ethnicity and SES. Referent: Non-Hispanic white (NHW) cases in same SES strata. Overall model interaction term P value for lung = .11, liver = .97, kidney = .09, colorectal = .05, prostate = .13, breast = 0. Absolute difference (AD) in survival compared with NHWs. A negative value indicates that survival was higher than in the NHW group. API = Asian/Pacific Islander; CRC = colorectal cancer; HISP = Hispanic; NHB = non-Hispanic black; Q = quintile; RD = relative disparity.
† P < .05.